Literature DB >> 21543403

WHO urges the phasing out of artemisinin based monotherapy for malaria to reduce resistance.

Weiyuan Cui.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543403     DOI: 10.1136/bmj.d2793

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  9 in total

1.  Re-Engineering of Yohimbine's Biological Activity through Ring Distortion: Identification and Structure-Activity Relationships of a New Class of Antiplasmodial Agents.

Authors:  Nicholas G Paciaroni; David L Perry; Verrill M Norwood; Claribel Murillo-Solano; Jennifer Collins; Srinivasarao Tenneti; Debopam Chakrabarti; Robert W Huigens
Journal:  ACS Infect Dis       Date:  2020-01-16       Impact factor: 5.084

2.  Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay.

Authors:  Stuart D Tyner; Chanthap Lon; Youry Se; Delia Bethell; Doung Socheat; Harald Noedl; Darapiseth Sea; Wichai Satimai; Kurt Schaecher; Wiriya Rutvisuttinunt; Mark M Fukuda; Suwanna Chaorattanakawee; Kritsanai Yingyuen; Siratchana Sundrakes; Panjaporn Chaichana; Piyaporn Saingam; Nillawan Buathong; Sabaithip Sriwichai; Soklyda Chann; Ans Timmermans; David L Saunders; Douglas S Walsh
Journal:  Malar J       Date:  2012-06-13       Impact factor: 2.979

Review 3.  Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis.

Authors:  Rong Liu; Hui-Fen Dong; Yi Guo; Qin-Ping Zhao; Ming-Sen Jiang
Journal:  Parasit Vectors       Date:  2011-10-17       Impact factor: 3.876

4.  Spirocyclic chromanes exhibit antiplasmodial activities and inhibit all intraerythrocytic life cycle stages.

Authors:  Bracken F Roberts; Iredia D Iyamu; Sukjun Lee; Eunyoung Lee; Lawrence Ayong; Dennis E Kyle; Yu Yuan; Roman Manetsch; Debopam Chakrabarti
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-02-12       Impact factor: 4.077

5.  4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle.

Authors:  Bracken F Roberts; Yongsheng Zheng; Jacob Cleaveleand; Sukjun Lee; Eunyoung Lee; Lawrence Ayong; Yu Yuan; Debopam Chakrabarti
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-02-21       Impact factor: 4.077

6.  Identification of Bis-Cyclic Guanidines as Antiplasmodial Compounds from Positional Scanning Mixture-Based Libraries.

Authors:  David L Perry; Bracken F Roberts; Ginamarie Debevec; Heather A Michaels; Debopam Chakrabarti; Adel Nefzi
Journal:  Molecules       Date:  2019-03-20       Impact factor: 4.411

7.  DeepMalaria: Artificial Intelligence Driven Discovery of Potent Antiplasmodials.

Authors:  Arash Keshavarzi Arshadi; Milad Salem; Jennifer Collins; Jiann Shiun Yuan; Debopam Chakrabarti
Journal:  Front Pharmacol       Date:  2020-01-15       Impact factor: 5.810

8.  Methods for implementing a medicine outlet survey: lessons from the anti-malarial market.

Authors:  Kathryn A O'Connell; Stephen Poyer; Tsione Solomon; Erik Munroe; Edith Patouillard; Julius Njogu; Illah Evance; Kara Hanson; Tanya Shewchuk; Catherine Goodman
Journal:  Malar J       Date:  2013-02-05       Impact factor: 2.979

9.  Antiplasmodial Compounds from Deep-Water Marine Invertebrates.

Authors:  Amy E Wright; Jennifer E Collins; Bracken Roberts; Jill C Roberts; Priscilla L Winder; John K Reed; Maria Cristina Diaz; Shirley A Pomponi; Debopam Chakrabarti
Journal:  Mar Drugs       Date:  2021-03-25       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.